Skip to content

Preterm Functional Early Enteral Development (FEED) Trial on Respiratory Support

Preterm Functional Early Enteral Development (FEED) Trial on Respiratory Support

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04531566
Enrollment
50
Registered
2020-08-28
Start date
2020-10-20
Completion date
2022-12-31
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Keywords

Prematurity, Oral Skills, Nasal CPAP oral feeds, HFNC oral feeds

Brief summary

The purpose of this study is to demonstrate that allowing infants that require high flow nasal cannula (HFNC)/Continuous positive airway pressure (CPAP) to orally feed if demonstrating oral cues will achieve full oral feeds faster.

Interventions

DIETARY_SUPPLEMENTOral Feed

Infant will be seen by occupational therapist (OT) twice a week and assessed for oral cues. If infant shows oral cues then the occupational therapist will proceed with feeding strategies. Oral feeding strategies include pacifier dips, open nipple trials with syringe controlled bolus size (1-4mls) and po trials up to 10mls.

DIETARY_SUPPLEMENTUsual care

Infants will not start oral feeds until on HFNC 2 Litres or less. Oral feeds will be started on the discretion of the physician.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
32 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

* infants that require greater than 2 litres per minute (LPM) high flow nasal canula or CPAP with a max setting of 6cm H20 FiO2 30% or less for at least 72 hours or more * Tolerating enteral feeds of 120 ml/kg/day

Exclusion criteria

* Major congenital anomalies (pulmonary malformations, airway malformations, craniofacial defects, major congenital heart disease, combined pulmonary intestinal malformations) * Metabolic disorder * Major gastrointestinal surgeries * Patent ductus arteriosus (PDA) ligation surgery * Outborn deliveries greater than 7 days old

Design outcomes

Primary

MeasureTime frameDescription
Post menstrual Age (PMA) once full oral feeds are achieved as documented by not requiring gavage tube feeds for at least 24 hours2 months after enrollmentMeasured in the electronic medical record

Secondary

MeasureTime frame
PMA at completion of first oral feed1 month after enrollment.
length of hospitalizationup to 6 months after admission
number of gastrostomy tubeup to 6 months after admission
oxygen at dischargeup to 6 months after admission
safety outcomes during the feed as measured by the number of desaturations2 months after enrollment
PMA at hospital dischargeup to 6 months after admission
safety outcomes during the feed as measured by the number of bradycardia episodes2 months after enrollment
safety outcomes as measured by the increase in fraction of inspired oxygen (FiO2) during and after feed2 months after enrollment
safety outcomes as measured by the increase in flow after feed2 months after enrollment
safety outcomes as measured by the number of choking episodes2 months after enrollment
safety outcomes as measured by the number of episodes of aspiration pneumonia2 months after enrollment
safety outcomes during the feed as measured by the number of apnea episodes2 months after enrollment

Countries

United States

Contacts

Primary ContactAshley N Morin, MD
Ashley.N.Morin@uth.tmc.edu(713) 500-5800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026